Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 68,408 | 73,740 | 14,192 | 0 | 0 |
| TOTAL | $69,944 | $74,731 | $15,165 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 1,808 | 476 | 400 | N/A | N/A |
| Other Non-Current Assets | 2,951 | 1,122 | 33 | 0 | 0 |
| TOTAL | $4,759 | $1,598 | $433 | $N/A | $N/A |
| Total Assets | $74,703 | $76,329 | $15,598 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,603 | 1,335 | 403 | 0 | 0 |
| Accrued Expenses | 3,035 | 1,801 | 494 | 0 | 0 |
| TOTAL | $5,638 | $3,136 | $897 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 217 | 172 | 3 | 0 | 0 |
| TOTAL | $1,267 | $194 | $23 | $N/A | $N/A |
| Total Liabilities | $6,905 | $3,330 | $920 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,024 | 2,191 | N/A | N/A | N/A |
| Common Shares | 2 | 2 | 1 | 0 | 0 |
| Retained earnings | -27,297 | -21,729 | -16,265 | 0 | 0 |
| Other shareholders' equity | 92,975 | 92,975 | 29,700 | 0 | 0 |
| TOTAL | $67,798 | $72,999 | $14,678 | $0 | $0 |
| Total Liabilities And Equity | $74,703 | $76,329 | $15,598 | $0 | $0 |